Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, Airfinity learned that there are bigger, more urgent questions the industry as a whole is struggling to answer: what is happening in a given therapy area right now and what is potentially next? Scientific conferences are an important source of this information, but only one among many. As a company, we realised that as an increasing amount of data became open and novel RWE data sources emerged, there was an opportunity to improve the intelligence driving key decisions in the life science space by not only connecting and linking these disparate and complex data sources but through advanced data science transform them into real-time actionable insights.
In 2017, we significantly expanded our data collection capabilities and in 2019 started offering a broader science intelligence solution with the aim of building the one go-to-place for real-time, predictive health analytics. Initially our focus was cardio-vascular diseases but soon certain areas of oncology were also added. This more ambitious purpose also had a personal angle; in 2018, Founder and CEO Rasmus Bech Hansen lost his mother to cancer after a 9-year battle during which he saw the desperate need for potential new treatments. In retrospect, Rasmus has said the experience instilled both him and the company with a stronger purpose; an urgency and realisation that better information can save lives.
When COVID-19 emerged in early 2020, we quickly saw that our proprietary technology and expertise perfectly positioned us to help the world better navigate an unprecedented situation. Across a sleepless few months the company built the world's first dedicated COVID-19 health analytics and intelligence platform which is now the trusted source of decision makers and media globally. Our data and forecasts have made a material difference to the global response to COVID-19; they have helped save lives.
Today, Airfinity is one of the fastest growing health data companies, serving clients on all major continents. Our hope is to continue to improve and find better ways to use data to empower decision makers to address more of humanity's big challenges.
Good decision making is essentially informed probability estimation. The best decision makers assess: if I do x, y is likely to happen. But what would be the outcome be if I did z? From the largest pharma groups to the individual doctor, these decisions are matters of life and death. The choice of R&D priorities, drug investment, a health policy to pursue or a treatment to prescribe has direct impact on lives.
At Airfinity, we recognise the gravity of these decisions. We provide scenario planning tools and forecasts that can be understood, relied upon and used for decision making. Our clients recognise that pure AI (and typically black box) solutions that deliver, at best, 80% accuracy are deeply insufficient. And they know from experience that static consultant reports and peer reviewed papers are too slow to stay ahead. These decision makers come to us for the alternative: intelligence and predictions that change as the world changes - an engine based on the global monitoring of millions of data points, structured information, careful curation and expert analysis in real time.
We mirror the life science community in our therapy area specialisation. We have become the world's leading source of COVID-19 intelligence but go much beyond that in cardiology, oncology and other critical areas. But we never compromise breath over depth. Instead we connect the dots and linkages within a given therapy area and sometimes between them. We go deep where others go broad. Ask us about the time lines of clinical trials, disease development, success probability of a given compound, future standard of care, revenue and market share, production and more and we can inform your decision making with the necessary scenario-based probabilities and forecast models - in days not months.
That's why Airfinity is the preferred solution for the decision makers who know that the cost of failure is the cost of lives.